Official Publications Abivax

Equities

Real-time Euronext Paris Other stock markets 03:11:03 2024-04-29 am EDT			5-day change	1st Jan Change
14.72 ^EUR	-0.67%		+2.22%	+49.90%

Apr. 11	Morgan Stanley Adjusts Price Target on Abivax to $16 From $15, Maintains Equalweight Rating	MT
Apr. 08	Transcript : ABIVAX Société Anonyme, 2023 Earnings Call, Apr 08, 2024

Combined general shareholders meeting	Apr. 23	CO
SEC Filing 20 F	Apr. 04	CO
Universal registration document	Apr. 04	CO
SEC Filing 4K	Apr. 01	CO
Annual results	Apr. 01	CO
Annual results	Apr. 01	CO
Annual results	Apr. 01	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	Mar. 04	CO
Monthly statement on voting rights	Feb. 28	CO
Changes in management and corporate officers	Feb. 06	CO
Monthly statement on voting rights	Jan. 30	CO
Provisional calendar	Jan. 03	CO
Monthly statement on voting rights	Dec. 30	CO
Corporate officers' Statement : Sale	Dec. 20	CO
Corporate officers' Statement : Sale	Dec. 12	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	Nov. 12	CO
Threshold crossings	Nov. 07	CO
Monthly statement on voting rights	23-10-30	CO
Corporate officers' Statement -: xercise of Stock Options 4	23-10-30	CO
Threshold crossings	23-10-26	CO
Threshold crossings	23-10-25	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	23-10-24	CO
Corporate officers' Statement -: xercise of Stock Options 4	23-10-23	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	23-10-23	CO
Amendment to the universal registration document	23-10-19	CO